|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | There is pressure to accelerate programs out of research, and into development. Then, despite the complexity of new drugs, therapies and technologies, process development chemists are asked to quick-step to clinical grade, and commercial-ready material. For their part, CDMOs need to react to it all. |
|
|
|
|
Critical Supply Strategies For CROs | White Paper | Catalent | Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy. |
|
|
|
|
|
Pinpoint Manufacturing Steps That Require Tighter Control | Case Study | By Daniel L. Kirschner, Ph.D. and Tom Lovelace, Cambrex | With a complete picture of the parameters that control each step during manufacturing, chemists can monitor and control individual reactions to optimize the production process. |
|
|
|
|
Solid Form Services | Brochure | Lonza | We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|